novartis
Entity, reached from Hormuz.
- Evidence
- 146 documents · 47 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 1 Aug 2026, last seen 9 Oct 2026
- Measured
- 23% of mentions say something specific about it; the rest only name it
- As of
- 10 Oct 2026
Where this comes from
- Fierce Pharma · 2026-10-09 · Fierce Pharma Asia—Novartis’ $7.8B mRNA deal; Shionogi’s $2B buy; ArriVent’s phase 3 flop (opens the source in a new tab)
- Endpoints News · 2026-10-09 · Curium prices generic radioligand at 5% discount to Novartis' Lutathera (opens the source in a new tab)
- AllSci News · 2026-10-08 · Novartis wins FDA nod to expand Rhapsido label to symptomatic dermographism (opens the source in a new tab)
- Endpoints News · 2026-10-07 · Novartis-partnered biotech nabs $150M Series B to move into the clinic (opens the source in a new tab)
- BioPharma Dive · 2026-10-05 · Novartis wagers almost $8B on a Chinese biotech’s RNA drugs (opens the source in a new tab)
- Pulse 2.0 · 2026-10-03 · Novartis Signs Up To $7.8 Billion Licensing Deal With Abogen For mRNA-Encoded T-Cell Engager (opens the source in a new tab)
- Fierce Pharma · 2026-10-02 · Proposed nuclear safety rules threaten to stall Novartis’ Pluvicto expansion (opens the source in a new tab)
- Endpoints News · 2026-10-02 · Novartis takes rights to Abogen's mRNA T cell engager for $575M upfront (opens the source in a new tab)
- AllSci News · 2026-10-02 · Novartis pays USD 575m upfront for Abogen’s mRNA-encoded in vivo autoimmune TCE (opens the source in a new tab)
- AllSci News · 2026-10-01 · Novartis and CAS build reaction-data backbone for AI drug discovery (opens the source in a new tab)
1 more on file, counted in the evidence above.
What is claimed about it
Situations it is named in
Who it moves with
- co-mentioned with roche (43 documents)seen together
- co-mentioned with fda (43 documents)seen together
- co-mentioned with astrazeneca (42 documents)seen together
- co-mentioned with eli lilly (39 documents)seen together
- co-mentioned with ai (34 documents)seen together
- co-mentioned with china (34 documents)seen together
- co-mentioned with merck (31 documents)seen together
- co-mentioned with amgen (28 documents)seen together
- co-mentioned with bristol myers squibb (27 documents)seen together
- co-mentioned with pfizer (26 documents)seen together